Institut Bergonié: Neoplasm Metastasis trials
The registry lists 12 Neoplasm Metastasis studies with Institut Bergonié as lead sponsor. 1 are open to participants now and 6 have results posted.
Phase 1 1Phase 2 5No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.RecruitingNCT06700057
- A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK StudyCompletedNCT04010240Results posted
- Patterns of Care and Outcomes in METAstatic Soft Tissue SARComaCompletedNCT03977818Results posted
- Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated OsteosarcomaCompletedNCT02517918Phase 1Results posted
- Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With CancerCompletedNCT00712712Phase 2Results posted
- PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung MetastasesCompletedNCT00382252Not applicableResults posted
- Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.CompletedNCT00210106Not applicableResults posted
- Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced SarcomaActive, not recruitingNCT04874311Phase 2
- Targeting ATR in Soft-tissue SarcomasCompletedNCT04807816Phase 2
- Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized StudyActive, not recruitingNCT04258137Not applicable
- Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyCompletedNCT04095208Phase 2
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2